Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysis

Dirk Rades, Ursula Schroeder, Amira Bajrovic, Steven E. Schild

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The standard treatment for non-metastatic T3/T4 larynx and hypopharynx cancer varies. This study compared definitive radiochemotherapy to surgery followed by radio(chemo)therapy. Forty-four patients treated with radiochemotherapy were matched to 88 patients receiving surgery plus radio(chemo)therapy. Groups were matched 1:2 for eight factors including age, gender, performance status, tumour site, histologic grade, T-/N-category and AJCC stage. Groups were compared for loco-regional control, metastases-free survival, overall survival and toxicity. Two-year loco-regional control rates were 75% after surgery plus radio(chemotherapy) and 66% after radiochemotherapy (p = 0.39). Metastases-free survival rates were 76% and 77%, respectively (p = 0.76). Overall survival rates were 67% and 63%, respectively (p = 0.95). During follow up, 60% and 9% of the patients, respectively, received a total laryngectomy (p = 0.004). Grade ≥3 oral mucositis and haematologic toxicity rates were higher with radiochemotherapy. Other toxicities were similar. Outcomes of radiochemotherapy appeared similar to those of surgery plus radio(chemo)therapy. The larynx preservation rate was higher after radiochemotherapy.

Original languageEnglish (US)
Pages (from-to)2729-2734
Number of pages6
JournalEuropean Journal of Cancer
Volume47
Issue number18
DOIs
StatePublished - Dec 2011

Fingerprint

Matched-Pair Analysis
Hypopharynx
Laryngeal Neoplasms
Chemoradiotherapy
Radio
Therapeutics
Survival Rate
Neoplasm Metastasis
Stomatitis
Laryngectomy
Survival
Age Factors
Larynx
Research Design
Drug Therapy
Neoplasms

Keywords

  • Hypopharynx cancer
  • Larynx cancer
  • Radiochemotherapy
  • Surgery
  • Treatment outcomes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysis. / Rades, Dirk; Schroeder, Ursula; Bajrovic, Amira; Schild, Steven E.

In: European Journal of Cancer, Vol. 47, No. 18, 12.2011, p. 2729-2734.

Research output: Contribution to journalArticle

Rades, Dirk ; Schroeder, Ursula ; Bajrovic, Amira ; Schild, Steven E. / Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysis. In: European Journal of Cancer. 2011 ; Vol. 47, No. 18. pp. 2729-2734.
@article{3e182049137c4771bf0241f4d9481825,
title = "Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysis",
abstract = "The standard treatment for non-metastatic T3/T4 larynx and hypopharynx cancer varies. This study compared definitive radiochemotherapy to surgery followed by radio(chemo)therapy. Forty-four patients treated with radiochemotherapy were matched to 88 patients receiving surgery plus radio(chemo)therapy. Groups were matched 1:2 for eight factors including age, gender, performance status, tumour site, histologic grade, T-/N-category and AJCC stage. Groups were compared for loco-regional control, metastases-free survival, overall survival and toxicity. Two-year loco-regional control rates were 75{\%} after surgery plus radio(chemotherapy) and 66{\%} after radiochemotherapy (p = 0.39). Metastases-free survival rates were 76{\%} and 77{\%}, respectively (p = 0.76). Overall survival rates were 67{\%} and 63{\%}, respectively (p = 0.95). During follow up, 60{\%} and 9{\%} of the patients, respectively, received a total laryngectomy (p = 0.004). Grade ≥3 oral mucositis and haematologic toxicity rates were higher with radiochemotherapy. Other toxicities were similar. Outcomes of radiochemotherapy appeared similar to those of surgery plus radio(chemo)therapy. The larynx preservation rate was higher after radiochemotherapy.",
keywords = "Hypopharynx cancer, Larynx cancer, Radiochemotherapy, Surgery, Treatment outcomes",
author = "Dirk Rades and Ursula Schroeder and Amira Bajrovic and Schild, {Steven E.}",
year = "2011",
month = "12",
doi = "10.1016/j.ejca.2011.06.013",
language = "English (US)",
volume = "47",
pages = "2729--2734",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "18",

}

TY - JOUR

T1 - Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysis

AU - Rades, Dirk

AU - Schroeder, Ursula

AU - Bajrovic, Amira

AU - Schild, Steven E.

PY - 2011/12

Y1 - 2011/12

N2 - The standard treatment for non-metastatic T3/T4 larynx and hypopharynx cancer varies. This study compared definitive radiochemotherapy to surgery followed by radio(chemo)therapy. Forty-four patients treated with radiochemotherapy were matched to 88 patients receiving surgery plus radio(chemo)therapy. Groups were matched 1:2 for eight factors including age, gender, performance status, tumour site, histologic grade, T-/N-category and AJCC stage. Groups were compared for loco-regional control, metastases-free survival, overall survival and toxicity. Two-year loco-regional control rates were 75% after surgery plus radio(chemotherapy) and 66% after radiochemotherapy (p = 0.39). Metastases-free survival rates were 76% and 77%, respectively (p = 0.76). Overall survival rates were 67% and 63%, respectively (p = 0.95). During follow up, 60% and 9% of the patients, respectively, received a total laryngectomy (p = 0.004). Grade ≥3 oral mucositis and haematologic toxicity rates were higher with radiochemotherapy. Other toxicities were similar. Outcomes of radiochemotherapy appeared similar to those of surgery plus radio(chemo)therapy. The larynx preservation rate was higher after radiochemotherapy.

AB - The standard treatment for non-metastatic T3/T4 larynx and hypopharynx cancer varies. This study compared definitive radiochemotherapy to surgery followed by radio(chemo)therapy. Forty-four patients treated with radiochemotherapy were matched to 88 patients receiving surgery plus radio(chemo)therapy. Groups were matched 1:2 for eight factors including age, gender, performance status, tumour site, histologic grade, T-/N-category and AJCC stage. Groups were compared for loco-regional control, metastases-free survival, overall survival and toxicity. Two-year loco-regional control rates were 75% after surgery plus radio(chemotherapy) and 66% after radiochemotherapy (p = 0.39). Metastases-free survival rates were 76% and 77%, respectively (p = 0.76). Overall survival rates were 67% and 63%, respectively (p = 0.95). During follow up, 60% and 9% of the patients, respectively, received a total laryngectomy (p = 0.004). Grade ≥3 oral mucositis and haematologic toxicity rates were higher with radiochemotherapy. Other toxicities were similar. Outcomes of radiochemotherapy appeared similar to those of surgery plus radio(chemo)therapy. The larynx preservation rate was higher after radiochemotherapy.

KW - Hypopharynx cancer

KW - Larynx cancer

KW - Radiochemotherapy

KW - Surgery

KW - Treatment outcomes

UR - http://www.scopus.com/inward/record.url?scp=82255162938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82255162938&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2011.06.013

DO - 10.1016/j.ejca.2011.06.013

M3 - Article

C2 - 21726998

AN - SCOPUS:82255162938

VL - 47

SP - 2729

EP - 2734

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 18

ER -